Scotland’s Life Sciences Dinner and Annual Awards | Sponsors
Scotland’s vibrant life sciences industry contributes more than £3 billion a year to the Scottish economy and is globally recognised for its impact and high levels of innovation.
Scotland, lifesciences, event, awards, business
page-template,page-template-full_width,page-template-full_width-php,page,page-id-16454,page-parent,cookies-not-set,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive




Over 26,000 people living in Scotland today have been diagnosed with bowel cancer – making it the third most common cancer in the country. Bowel cancer is also the nation’s second biggest cancer killer, however it shouldn’t be because it is treatable and curable especially if diagnosed early. That’s why we’ve teamed up with Bowel Cancer UK as our exclusive fundraiser for our Dinner and Annual Awards on Thursday 28 February 2019.

Bowel Cancer UK is the UK’s leading bowel cancer charity. They support and fund targeted research, provide expert information and support to patients and their families, educate the public and professionals about the disease and campaign for early diagnosis and access to best treatment and care.

Money raised from our award ceremony will go towards their ambitious ‘Improving Surgery, Saving Lives’ fundraising appeal. They need our help to raise £430,000 for surgical bowel cancer research to establish Scotland’s first Colorectal Cancer Surgical Research Chair, in partnership with the Royal College of Surgeons of Edinburgh.

The research chair will drive forward the surgical clinical trial agenda for bowel cancer, growing the number of surgical trials focussed on bowel cancer and increasing patient access to them in Scotland.

Bowel Cancer UK will be joining us at our Dinner and Annual Awards, where you will have the opportunity to find out more about the project and donate to their appeal.

To find out more about the ‘Improving Surgery, Saving Lives’ appeal, email:



Highlands and Islands Enterprise (HIE) is the economic and community development agency delivering the Scottish Government’s economic strategy across the north and west of Scotland, a region which covers more than half of Scotland.

With around 300 staff, HIE supports hundreds of client businesses and social enterprises; strengthens communities, particularly in fragile areas; develops key sectors, and invests in infrastructure to create a more competitive and low carbon region.

As one of our priority sectors for growth, Life Sciences are key to the economic development of our region. In particular the sub-sectors Medical Technologies and Diagnostics, Digital Health and Marine Biotechnology play an important role and are well represented across the business base and academic expertise


The College of Medical, Veterinary and Life Sciences (MVLS) brings together internationally renowned experts and state-of-the-art facilities to improve health and quality of life for humans and animals across the globe.  The College also provides innovative teaching for students, preparing them for a wide variety of exciting careers.

MVLS has developed the Clinical Innovation Zone at the Queen Elizabeth University hospital, which provides a vibrant and growing ecosystem where industry partners can co-locate with world leading academic and clinical experts at the heart of Europe’s largest hospital campus.


Piramal Pharma Solutions is a contract development and manufacturing organisation (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our clients through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms. We also offer specialised services like development and manufacture of Highly Potent APIs, Antibody Drug Conjugation and are well versed in technologies such as Bio-catalysis.


For over 65 years, GSK’s Montrose facility has manufactured many of the company’s most important products. Currently, the site makes enough medicine to serve over 20 million patients every day, a figure set to rise following the recent £54 million investment in a new state-of-the-art facility for the manufacture of its latest, innovative respiratory medicines.


EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalised experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents. Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient‑centric operating models.

Our Global Life Sciences Sector brings together a worldwide network of nearly 17,000 sector‑focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health‑ outcomes‑driven ecosystem.



Skills Development Scotland is the national skills body supporting the people and businesses of Scotland to develop and apply their skills.

With more than 1,400 colleagues working across the country in schools, careers centres and partner locations, we are passionate about skills development and its contribution to a modern, innovative and prosperous Scottish economy.

Working with our partners, we strive to ensure employers have the right skills at the right time in high performing, fair and equal workplaces, and that every individual has the skills and confidence to get a job and progress in the workplace, achieving their full potential.


Haseltine Lake is a major European Intellectual Property practice. With decades of experience in helping life sciences businesses protect their valuable innovations, Haseltine Lake can unlock the power of your IP.

Our team of highly qualified attorneys across a number of European offices in Glasgow, London, Bristol, Munich and the Netherlands, can help you get the protection you need, and make your IP budget go further. Founded in 1850, Haseltine Lake enjoys long-standing, closely integrated relationships with its clients, based on trust, transparency and flexibility.


Opportunity North East (ONE) is a privately funded and led economic development body, set up to strengthen and diversify the economy of North East Scotland and has a 10-year £62m funding commitment from The Wood Foundation.

The ONE Life Sciences sector board is leading ambitious action and investment to realise the life sciences innovation, collaboration and commercialisation opportunity in Aberdeen, focused on the city’s Foresterhill Health Campus, one of Europe’s largest integrated clinical, research and teaching sites. This includes the creation of the Bio-therapeutics Hub for Innovation, a £40m investment that aims to double the number of life sciences companies based in the region. It will provide the physical space and specialist support to accelerate the creation and growth of companies, putting the regional company cluster and wider asset base at the forefront of health innovation and commercialisation. The project has been developed by ONE Life Sciences, University of Aberdeen, Robert Gordon University, NHS Grampian and Scottish Enterprise and the ONE team is leading its delivery. It has secured £20m of capital funding via the Aberdeen City Region Deal and ONE has committed £3.6m of funding to it. The new-build facility is due to open at the end of 2020.


Hyper Recruitment Solutions (HRS), is a specialist and highly compliant recruitment consultancy, dedicated to the science, engineering and technology sectors. Founded and run by Ricky Martin, in partnership with Lord Alan Sugar, HRS has a wealth of recruitment expertise as well as outstanding compliance and commercial awareness.


We offer a range of permanent, temporary and contract staff on both a contingent and retained basis. Our vision is to provide recruitment solutions which change lives. To do so, HRS focuses on supporting sectors whose primary focus is to make the world a better place.


Marks & Clerk is an international group of intellectual property service providers, encompassing patent attorneys, trade mark attorneys, lawyers and consultants. Operating internationally with 17 offices worldwide, our clients range from individuals with good ideas to multi-nationals with large IP portfolios.


Marks & Clerk enjoys long-established presence in Scotland, including offices in Edinburgh, Glasgow and Aberdeen.  We work closely with many Scottish start-ups, SMEs, universities and investors.


Eurofins Biopharma Product Testing UK has over 30 years’ experience providing high quality testing, development and stability services to the pharmaceutical and biopharmaceutical industry.

We are part of the largest network of harmonised GMP product testing labs in the world with access to:

  • 34 Laboratory locations in over 17 countries
  • Full range of large and small molecule testing
  • Medical device testing

We continue to uphold our founding promise of personal service and impeccable quality. Extensive expertise and a wide range of instrument capabilities allow us to provide one-stop-shop GMP services for our clients, reducing costs and delivery times.


With over 1,100 staff located at its Edinburgh sites, Charles River provides contract research services to help global pharmaceutical and biotechnology companies accelerate their research and drug development efforts.  Charles River’s dedicated employees provide the expertise required to expedite the discovery, development and safe manufacture of new therapies for patients.



The Scotsman has played a vital part in forming and reporting national opinion for over 200 years. First published in 1817, The Scotsman is firmly established as a quality daily Scottish newspaper, with a reputation for original thinking and thought-provoking writing.